The European stem cell market is one of the most rapidly growing markets. The market is currently valued at USD 4.2 billion and is expected to grow at a CAGR of 15.7% over a forecast period.
Europe’s Stem Cells Market- Market Dynamics
Stem cell research is one of the most exciting areas of science in the 21st century and has the potential to revolutionize the way we treat conditions, including degenerative diseases for which few effective treatments currently exist. Researchers, governments, and the general public have high expectations from this field and they hope that this research will one day produce great results that might cure diseases such as Parkinson's, Diabetes, Cancer and Alzheimer's.
There are several factors driving the growth of the stem cells market in Europe. Some of these are:
Although there is ample scope for growth in the stem cells market in Europe, there are factors restraining it as well. Some of them are:
The stem cell research market is segmented on the basis of service, therapeutic application, treatment, and geography. In the stem cell segmentation by service mode, stem cell banking occupies the majority share of the market. In stem cell segmentation by treatment mode, allogeneic stem cell therapy market occupies the majority share. On the basis of geography, the market has been segmented into the UK, Spain, Germany, France and Denmark.
Some of the key players in the market are:
Key Deliverables in the Study
Looking to Customize Report?